Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Life as an African health minister

What is really like to be a Minister of Health for an African country such as Tanzania where per capital healthcare expenditure is $41 compared to $9,000 for Switzerland? A fascinating session at Africa Summit saw ministers from Tanzania, Zambia and Ghana revealing all. Certainly, there are hiccups. Ghana saw its entire Medical Supplies Department […]

Operational challenges hinder China’s hospital privatisation

As the Chinese government aims to privatise healthcare, different models of integration are emerging. PPPs, private investments, and Sino-Foreign Joint Ventures (JVs) are the most common, although important operational challenges remain. We look at the issues.

Bupa to raise its stake in India

British private healthcare group Bupa is looking to expand quickly in India's fast-growing health insurance market once a rule change on foreign investment is implemented.

Apollo backs cancer diagnostic group

Sapien Biosciences, backed by India’s Apollo Hospitals, has entered into collaboration with Bangalore-based diagnostic start-up OncoStem Diagnostics to develop a breast cancer recurrence prediction test.

FREE BLOG What is the real reach for B to C telehealth?

Evangelists like Ali Parsa, the founder and CEO of Babylon Health, an app which lets consumers bypass waiting times and communicate with a doctor, reckon that such business to consumer telehealth apps will make a real difference to healthcare in poor countries. But will they?

Clinica Baviera pre-tax profit falls by 23%

Clinica Baviera, Europe’s only quoted ophthalmology group, increased sales by over 3% but with pre-tax profit and EBITDA both down, its overall performance appears to have been hamstrung by its international operations. We speak to Meritxell Pérez de Castro-Acuña, head of investor relations at Clinica Baviera, about its results.

Lifebrain hoovers up Italian labs

Austrian lab group Lifebrain has completed a new bout of acquisitions across Italy. Three labs have been added to its fold: Salus in Lazio, Euromedical & Lab in Bologna, and Biomedical in Puglia.

Bupa acquisitions pay off

The £1.6bn spent by new Bupa CEO Stuart Fletcher are paying off with 2014 sales ahead 15% at constant exchange rates at £9.8bn in 2014. We talk to him about PMI, deals with hospitals and future plans.

Svet Zdravia and Agel battle for privatisation contract

Slovakia is slowly moving toward the privatisation of healthcare, with new hospitals being built and state assets being sold. Martin Hrežo, CFO of Svet Zdravia, Slovakia’s biggest group with 12 hospitals, explains what’s going on.

Find Us